Lawmaker Proposes FDA-style Agency for AI Oversight

Rep. Ro Khanna (D-Calif.) has called for the establishment of a new government agency to oversee artificial intelligence, modeled after the Food and Drug Administration. Speaking on CBS News, the California Democrat argued that the federal government must take a direct regulatory role rather than relying on the voluntary restraint of tech executives. He emphasized that complex technologies like nuclear energy and aviation are already managed by independent technical experts, suggesting that AI should be treated with similar rigor to ensure public safety.

The proposal comes amid growing concerns among bipartisan lawmakers about the potential existential threats posed by advanced AI systems. While some industry leaders argue that Washington lacks the technical understanding to regulate such complex fields, Khanna rejected this notion. He pointed out that Congress has successfully regulated intricate systems in the past and can appoint smart, independent experts from universities to perform the same function for AI, ensuring that safety standards are met before widespread deployment.

International standards and verification needed

Khanna stressed that domestic regulation alone is insufficient without an international agreement, particularly with China. He highlighted two primary dangers: the loss of control over the technology and its potential misuse. Citing the need for trust and verification, he suggested that any agreement with Chinese President Xi Jinping should include basic standards for monitoring and checks through data centers. This approach mirrors arms control treaties, where verification mechanisms are essential to ensure compliance and prevent catastrophic outcomes for civilization.

The debate over AI governance has intensified as former Anthropic researchers have warned that the technology could pose an existential threat to human life. In contrast, President Trump has dismissed these warnings as a hoax while announcing plans to create an "AI Force" and appoint an "AI czar." Critics, including former President Barack Obama, have argued that relying on market forces to "take care" of AI contradicts established regulatory practices in industries like aviation and pharmaceuticals, where government oversight is standard.

Trade-offs between innovation and safety

The core of the argument revolves around the trade-off between rapid innovation and public safety. Khanna’s proposal implies that the current pace of AI development is too fast to be safely managed by private companies alone. By creating a dedicated agency, the government could set guardrails that slow down deployment only where necessary, allowing for rigorous safety testing. This approach aims to balance the economic benefits of AI with the need to mitigate risks that could have irreversible consequences for society.

As the U.S. prepares for a state visit from President Xi, the pressure to establish clear regulatory frameworks is mounting. The Hill reports that Khanna has already sent letters to major AI companies, urging them to slow down advancements until proper guardrails are in place. The outcome of these discussions will likely shape the future of AI governance, determining whether the technology is developed with robust safety measures or left to the discretion of private actors with varying priorities.